Global Transcriptome Sequencing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

January 2026 | 114 pages | ID: G51CA406A71BEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Transcriptome Sequencing market size was valued at US$ 2821 million in 2025 and is forecast to a readjusted size of US$ 6923 million by 2032 with a CAGR of 13.8% during review period.

Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5? and 3? terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.

The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.

This report is a detailed and comprehensive analysis for global Transcriptome Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Transcriptome Sequencing market size and forecasts, in consumption value ($ Million), 2021-2032

Global Transcriptome Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Transcriptome Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Transcriptome Sequencing market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcriptome Sequencing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Transcriptome Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Transcriptome Sequencing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Coding RNA
  • Noncoding RNA
Market segment by Application
  • Biomedical Field
  • Non-medical Field
Market segment by players, this report covers
  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Roche
  • Bio-Rad
  • Agilent Technologies
  • LabCorp
  • QIAGEN
  • Pacific Biosciences
  • Azenta
  • BGI Genomics
  • Novogene
  • Macrogen
  • Shanghai ZJ Bio-Tech
  • Tsingke Biotechnology
Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Transcriptome Sequencing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Transcriptome Sequencing, with revenue, gross margin, and global market share of Transcriptome Sequencing from 2021 to 2026.

Chapter 3, the Transcriptome Sequencing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Transcriptome Sequencing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Transcriptome Sequencing.

Chapter 13, to describe Transcriptome Sequencing research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Transcriptome Sequencing by Type
  1.3.1 Overview: Global Transcriptome Sequencing Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Transcriptome Sequencing Consumption Value Market Share by Type in 2025
  1.3.3 Coding RNA
  1.3.4 Noncoding RNA
1.4 Global Transcriptome Sequencing Market by Application
  1.4.1 Overview: Global Transcriptome Sequencing Market Size by Application: 2021 Versus 2025 Versus 2032
  1.4.2 Biomedical Field
  1.4.3 Non-medical Field
1.5 Global Transcriptome Sequencing Market Size & Forecast
1.6 Global Transcriptome Sequencing Market Size and Forecast by Region
  1.6.1 Global Transcriptome Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  1.6.2 Global Transcriptome Sequencing Market Size by Region, (2021-2032)
  1.6.3 North America Transcriptome Sequencing Market Size and Prospect (2021-2032)
  1.6.4 Europe Transcriptome Sequencing Market Size and Prospect (2021-2032)
  1.6.5 Asia-Pacific Transcriptome Sequencing Market Size and Prospect (2021-2032)
  1.6.6 South America Transcriptome Sequencing Market Size and Prospect (2021-2032)
  1.6.7 Middle East & Africa Transcriptome Sequencing Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Illumina
  2.1.1 Illumina Details
  2.1.2 Illumina Major Business
  2.1.3 Illumina Transcriptome Sequencing Product and Solutions
  2.1.4 Illumina Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Illumina Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
  2.2.1 Thermo Fisher Scientific Details
  2.2.2 Thermo Fisher Scientific Major Business
  2.2.3 Thermo Fisher Scientific Transcriptome Sequencing Product and Solutions
  2.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Eurofins Scientific
  2.3.1 Eurofins Scientific Details
  2.3.2 Eurofins Scientific Major Business
  2.3.3 Eurofins Scientific Transcriptome Sequencing Product and Solutions
  2.3.4 Eurofins Scientific Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Eurofins Scientific Recent Developments and Future Plans
2.4 Roche
  2.4.1 Roche Details
  2.4.2 Roche Major Business
  2.4.3 Roche Transcriptome Sequencing Product and Solutions
  2.4.4 Roche Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Roche Recent Developments and Future Plans
2.5 Bio-Rad
  2.5.1 Bio-Rad Details
  2.5.2 Bio-Rad Major Business
  2.5.3 Bio-Rad Transcriptome Sequencing Product and Solutions
  2.5.4 Bio-Rad Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 Agilent Technologies
  2.6.1 Agilent Technologies Details
  2.6.2 Agilent Technologies Major Business
  2.6.3 Agilent Technologies Transcriptome Sequencing Product and Solutions
  2.6.4 Agilent Technologies Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Agilent Technologies Recent Developments and Future Plans
2.7 LabCorp
  2.7.1 LabCorp Details
  2.7.2 LabCorp Major Business
  2.7.3 LabCorp Transcriptome Sequencing Product and Solutions
  2.7.4 LabCorp Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 LabCorp Recent Developments and Future Plans
2.8 QIAGEN
  2.8.1 QIAGEN Details
  2.8.2 QIAGEN Major Business
  2.8.3 QIAGEN Transcriptome Sequencing Product and Solutions
  2.8.4 QIAGEN Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 QIAGEN Recent Developments and Future Plans
2.9 Pacific Biosciences
  2.9.1 Pacific Biosciences Details
  2.9.2 Pacific Biosciences Major Business
  2.9.3 Pacific Biosciences Transcriptome Sequencing Product and Solutions
  2.9.4 Pacific Biosciences Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Pacific Biosciences Recent Developments and Future Plans
2.10 Azenta
  2.10.1 Azenta Details
  2.10.2 Azenta Major Business
  2.10.3 Azenta Transcriptome Sequencing Product and Solutions
  2.10.4 Azenta Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Azenta Recent Developments and Future Plans
2.11 BGI Genomics
  2.11.1 BGI Genomics Details
  2.11.2 BGI Genomics Major Business
  2.11.3 BGI Genomics Transcriptome Sequencing Product and Solutions
  2.11.4 BGI Genomics Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 BGI Genomics Recent Developments and Future Plans
2.12 Novogene
  2.12.1 Novogene Details
  2.12.2 Novogene Major Business
  2.12.3 Novogene Transcriptome Sequencing Product and Solutions
  2.12.4 Novogene Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Novogene Recent Developments and Future Plans
2.13 Macrogen
  2.13.1 Macrogen Details
  2.13.2 Macrogen Major Business
  2.13.3 Macrogen Transcriptome Sequencing Product and Solutions
  2.13.4 Macrogen Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Macrogen Recent Developments and Future Plans
2.14 Shanghai ZJ Bio-Tech
  2.14.1 Shanghai ZJ Bio-Tech Details
  2.14.2 Shanghai ZJ Bio-Tech Major Business
  2.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Product and Solutions
  2.14.4 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Shanghai ZJ Bio-Tech Recent Developments and Future Plans
2.15 Tsingke Biotechnology
  2.15.1 Tsingke Biotechnology Details
  2.15.2 Tsingke Biotechnology Major Business
  2.15.3 Tsingke Biotechnology Transcriptome Sequencing Product and Solutions
  2.15.4 Tsingke Biotechnology Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Tsingke Biotechnology Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Transcriptome Sequencing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Transcriptome Sequencing by Company Revenue
  3.2.2 Top 3 Transcriptome Sequencing Players Market Share in 2025
  3.2.3 Top 6 Transcriptome Sequencing Players Market Share in 2025
3.3 Transcriptome Sequencing Market: Overall Company Footprint Analysis
  3.3.1 Transcriptome Sequencing Market: Region Footprint
  3.3.2 Transcriptome Sequencing Market: Company Product Type Footprint
  3.3.3 Transcriptome Sequencing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Transcriptome Sequencing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Transcriptome Sequencing Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Transcriptome Sequencing Consumption Value Market Share by Application (2021-2026)
5.2 Global Transcriptome Sequencing Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Transcriptome Sequencing Consumption Value by Type (2021-2032)
6.2 North America Transcriptome Sequencing Market Size by Application (2021-2032)
6.3 North America Transcriptome Sequencing Market Size by Country
  6.3.1 North America Transcriptome Sequencing Consumption Value by Country (2021-2032)
  6.3.2 United States Transcriptome Sequencing Market Size and Forecast (2021-2032)
  6.3.3 Canada Transcriptome Sequencing Market Size and Forecast (2021-2032)
  6.3.4 Mexico Transcriptome Sequencing Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Transcriptome Sequencing Consumption Value by Type (2021-2032)
7.2 Europe Transcriptome Sequencing Consumption Value by Application (2021-2032)
7.3 Europe Transcriptome Sequencing Market Size by Country
  7.3.1 Europe Transcriptome Sequencing Consumption Value by Country (2021-2032)
  7.3.2 Germany Transcriptome Sequencing Market Size and Forecast (2021-2032)
  7.3.3 France Transcriptome Sequencing Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Transcriptome Sequencing Market Size and Forecast (2021-2032)
  7.3.5 Russia Transcriptome Sequencing Market Size and Forecast (2021-2032)
  7.3.6 Italy Transcriptome Sequencing Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Transcriptome Sequencing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Transcriptome Sequencing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Transcriptome Sequencing Market Size by Region
  8.3.1 Asia-Pacific Transcriptome Sequencing Consumption Value by Region (2021-2032)
  8.3.2 China Transcriptome Sequencing Market Size and Forecast (2021-2032)
  8.3.3 Japan Transcriptome Sequencing Market Size and Forecast (2021-2032)
  8.3.4 South Korea Transcriptome Sequencing Market Size and Forecast (2021-2032)
  8.3.5 India Transcriptome Sequencing Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Transcriptome Sequencing Market Size and Forecast (2021-2032)
  8.3.7 Australia Transcriptome Sequencing Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Transcriptome Sequencing Consumption Value by Type (2021-2032)
9.2 South America Transcriptome Sequencing Consumption Value by Application (2021-2032)
9.3 South America Transcriptome Sequencing Market Size by Country
  9.3.1 South America Transcriptome Sequencing Consumption Value by Country (2021-2032)
  9.3.2 Brazil Transcriptome Sequencing Market Size and Forecast (2021-2032)
  9.3.3 Argentina Transcriptome Sequencing Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Transcriptome Sequencing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Transcriptome Sequencing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Transcriptome Sequencing Market Size by Country
  10.3.1 Middle East & Africa Transcriptome Sequencing Consumption Value by Country (2021-2032)
  10.3.2 Turkey Transcriptome Sequencing Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Transcriptome Sequencing Market Size and Forecast (2021-2032)
  10.3.4 UAE Transcriptome Sequencing Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Transcriptome Sequencing Market Drivers
11.2 Transcriptome Sequencing Market Restraints
11.3 Transcriptome Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Transcriptome Sequencing Industry Chain
12.2 Transcriptome Sequencing Upstream Analysis
12.3 Transcriptome Sequencing Midstream Analysis
12.4 Transcriptome Sequencing Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


LIST OF FIGURES

Table 1. Global Transcriptome Sequencing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Transcriptome Sequencing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Transcriptome Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Transcriptome Sequencing Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Transcriptome Sequencing Product and Solutions
Table 8. Illumina Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Illumina Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Transcriptome Sequencing Product and Solutions
Table 13. Thermo Fisher Scientific Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. Eurofins?Scientific Company Information, Head Office, and Major Competitors
Table 16. Eurofins?Scientific Major Business
Table 17. Eurofins?Scientific Transcriptome Sequencing Product and Solutions
Table 18. Eurofins?Scientific Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Roche Company Information, Head Office, and Major Competitors
Table 20. Roche Major Business
Table 21. Roche Transcriptome Sequencing Product and Solutions
Table 22. Roche Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Roche Recent Developments and Future Plans
Table 24. Bio-Rad Company Information, Head Office, and Major Competitors
Table 25. Bio-Rad Major Business
Table 26. Bio-Rad Transcriptome Sequencing Product and Solutions
Table 27. Bio-Rad Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Bio-Rad Recent Developments and Future Plans
Table 29. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 30. Agilent Technologies Major Business
Table 31. Agilent Technologies Transcriptome Sequencing Product and Solutions
Table 32. Agilent Technologies Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Agilent Technologies Recent Developments and Future Plans
Table 34. LabCorp Company Information, Head Office, and Major Competitors
Table 35. LabCorp Major Business
Table 36. LabCorp Transcriptome Sequencing Product and Solutions
Table 37. LabCorp Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. LabCorp Recent Developments and Future Plans
Table 39. QIAGEN Company Information, Head Office, and Major Competitors
Table 40. QIAGEN Major Business
Table 41. QIAGEN Transcriptome Sequencing Product and Solutions
Table 42. QIAGEN Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. QIAGEN Recent Developments and Future Plans
Table 44. Pacific Biosciences Company Information, Head Office, and Major Competitors
Table 45. Pacific Biosciences Major Business
Table 46. Pacific Biosciences Transcriptome Sequencing Product and Solutions
Table 47. Pacific Biosciences Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Pacific Biosciences Recent Developments and Future Plans
Table 49. Azenta Company Information, Head Office, and Major Competitors
Table 50. Azenta Major Business
Table 51. Azenta Transcriptome Sequencing Product and Solutions
Table 52. Azenta Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Azenta Recent Developments and Future Plans
Table 54. BGI Genomics Company Information, Head Office, and Major Competitors
Table 55. BGI Genomics Major Business
Table 56. BGI Genomics Transcriptome Sequencing Product and Solutions
Table 57. BGI Genomics Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. BGI Genomics Recent Developments and Future Plans
Table 59. Novogene Company Information, Head Office, and Major Competitors
Table 60. Novogene Major Business
Table 61. Novogene Transcriptome Sequencing Product and Solutions
Table 62. Novogene Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Novogene Recent Developments and Future Plans
Table 64. Macrogen Company Information, Head Office, and Major Competitors
Table 65. Macrogen Major Business
Table 66. Macrogen Transcriptome Sequencing Product and Solutions
Table 67. Macrogen Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Macrogen Recent Developments and Future Plans
Table 69. Shanghai ZJ Bio-Tech Company Information, Head Office, and Major Competitors
Table 70. Shanghai ZJ Bio-Tech Major Business
Table 71. Shanghai ZJ Bio-Tech Transcriptome Sequencing Product and Solutions
Table 72. Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Shanghai ZJ Bio-Tech Recent Developments and Future Plans
Table 74. Tsingke Biotechnology Company Information, Head Office, and Major Competitors
Table 75. Tsingke Biotechnology Major Business
Table 76. Tsingke Biotechnology Transcriptome Sequencing Product and Solutions
Table 77. Tsingke Biotechnology Transcriptome Sequencing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Tsingke Biotechnology Recent Developments and Future Plans
Table 79. Global Transcriptome Sequencing Revenue (USD Million) by Players (2021-2026)
Table 80. Global Transcriptome Sequencing Revenue Share by Players (2021-2026)
Table 81. Breakdown of Transcriptome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Transcriptome Sequencing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 83. Head Office of Key Transcriptome Sequencing Players
Table 84. Transcriptome Sequencing Market: Company Product Type Footprint
Table 85. Transcriptome Sequencing Market: Company Product Application Footprint
Table 86. Transcriptome Sequencing New Market Entrants and Barriers to Market Entry
Table 87. Transcriptome Sequencing Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Transcriptome Sequencing Consumption Value (USD Million) by Type (2021-2026)
Table 89. Global Transcriptome Sequencing Consumption Value Share by Type (2021-2026)
Table 90. Global Transcriptome Sequencing Consumption Value Forecast by Type (2027-2032)
Table 91. Global Transcriptome Sequencing Consumption Value by Application (2021-2026)
Table 92. Global Transcriptome Sequencing Consumption Value Forecast by Application (2027-2032)
Table 93. North America Transcriptome Sequencing Consumption Value by Type (2021-2026) & (USD Million)
Table 94. North America Transcriptome Sequencing Consumption Value by Type (2027-2032) & (USD Million)
Table 95. North America Transcriptome Sequencing Consumption Value by Application (2021-2026) & (USD Million)
Table 96. North America Transcriptome Sequencing Consumption Value by Application (2027-2032) & (USD Million)
Table 97. North America Transcriptome Sequencing Consumption Value by Country (2021-2026) & (USD Million)
Table 98. North America Transcriptome Sequencing Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Europe Transcriptome Sequencing Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Europe Transcriptome Sequencing Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Europe Transcriptome Sequencing Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Europe Transcriptome Sequencing Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Europe Transcriptome Sequencing Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Europe Transcriptome Sequencing Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Asia-Pacific Transcriptome Sequencing Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Asia-Pacific Transcriptome Sequencing Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Asia-Pacific Transcriptome Sequencing Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Asia-Pacific Transcriptome Sequencing Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Asia-Pacific Transcriptome Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Transcriptome Sequencing Consumption Value by Region (2027-2032) & (USD Million)
Table 111. South America Transcriptome Sequencing Consumption Value by Type (2021-2026) & (USD Million)
Table 112. South America Transcriptome Sequencing Consumption Value by Type (2027-2032) & (USD Million)
Table 113. South America Transcriptome Sequencing Consumption Value by Application (2021-2026) & (USD Million)
Table 114. South America Transcriptome Sequencing Consumption Value by Application (2027-2032) & (USD Million)
Table 115. South America Transcriptome Sequencing Consumption Value by Country (2021-2026) & (USD Million)
Table 116. South America Transcriptome Sequencing Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Middle East & Africa Transcriptome Sequencing Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Middle East & Africa Transcriptome Sequencing Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Middle East & Africa Transcriptome Sequencing Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Middle East & Africa Transcriptome Sequencing Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Middle East & Africa Transcriptome Sequencing Consumption Value by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Transcriptome Sequencing Consumption Value by Country (2027-2032) & (USD Million)
Table 123. Global Key Players of Transcriptome Sequencing Upstream (Raw Materials)
Table 124. Global Transcriptome Sequencing Typical Customers

LIST OF FIGURES

Figure 1. Transcriptome Sequencing Picture
Figure 2. Global Transcriptome Sequencing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Transcriptome Sequencing Consumption Value Market Share by Type in 2025
Figure 4. Coding RNA
Figure 5. Noncoding RNA
Figure 6. Global Transcriptome Sequencing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Transcriptome Sequencing Consumption Value Market Share by Application in 2025
Figure 8. Biomedical Field Picture
Figure 9. Non-medical Field Picture
Figure 10. Global Transcriptome Sequencing Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global Transcriptome Sequencing Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Market Transcriptome Sequencing Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 13. Global Transcriptome Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 14. Global Transcriptome Sequencing Consumption Value Market Share by Region in 2025
Figure 15. North America Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 16. Europe Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 17. Asia-Pacific Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 18. South America Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 19. Middle East & Africa Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global Transcriptome Sequencing Revenue Share by Players in 2025
Figure 22. Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 23. Market Share of Transcriptome Sequencing by Player Revenue in 2025
Figure 24. Top 3 Transcriptome Sequencing Players Market Share in 2025
Figure 25. Top 6 Transcriptome Sequencing Players Market Share in 2025
Figure 26. Global Transcriptome Sequencing Consumption Value Share by Type (2021-2026)
Figure 27. Global Transcriptome Sequencing Market Share Forecast by Type (2027-2032)
Figure 28. Global Transcriptome Sequencing Consumption Value Share by Application (2021-2026)
Figure 29. Global Transcriptome Sequencing Market Share Forecast by Application (2027-2032)
Figure 30. North America Transcriptome Sequencing Consumption Value Market Share by Type (2021-2032)
Figure 31. North America Transcriptome Sequencing Consumption Value Market Share by Application (2021-2032)
Figure 32. North America Transcriptome Sequencing Consumption Value Market Share by Country (2021-2032)
Figure 33. United States Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 34. Canada Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 35. Mexico Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Transcriptome Sequencing Consumption Value Market Share by Type (2021-2032)
Figure 37. Europe Transcriptome Sequencing Consumption Value Market Share by Application (2021-2032)
Figure 38. Europe Transcriptome Sequencing Consumption Value Market Share by Country (2021-2032)
Figure 39. Germany Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 40. France Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 41. United Kingdom Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 42. Russia Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 43. Italy Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 44. Asia-Pacific Transcriptome Sequencing Consumption Value Market Share by Type (2021-2032)
Figure 45. Asia-Pacific Transcriptome Sequencing Consumption Value Market Share by Application (2021-2032)
Figure 46. Asia-Pacific Transcriptome Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 47. China Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 48. Japan Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 49. South Korea Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 50. India Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 51. Southeast Asia Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 52. Australia Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 53. South America Transcriptome Sequencing Consumption Value Market Share by Type (2021-2032)
Figure 54. South America Transcriptome Sequencing Consumption Value Market Share by Application (2021-2032)
Figure 55. South America Transcriptome Sequencing Consumption Value Market Share by Country (2021-2032)
Figure 56. Brazil Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 57. Argentina Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 58. Middle East & Africa Transcriptome Sequencing Consumption Value Market Share by Type (2021-2032)
Figure 59. Middle East & Africa Transcriptome Sequencing Consumption Value Market Share by Application (2021-2032)
Figure 60. Middle East & Africa Transcriptome Sequencing Consumption Value Market Share by Country (2021-2032)
Figure 61. Turkey Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 62. Saudi Arabia Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 63. UAE Transcriptome Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 64. Transcriptome Sequencing Market Drivers
Figure 65. Transcriptome Sequencing Market Restraints
Figure 66. Transcriptome Sequencing Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Transcriptome Sequencing Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source


More Publications